Brian Ritchie
Investor Relations, Lightside Avire
Replay available
Relmada Therapeutics, Inc. (RLMD) Q1 2025 Earnings Call
Relmada Therapeutics, Inc. (NASDAQ: RLMD) Q1 2025 earnings conference call, held 2025-05-12. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Sergio Traversa
Chief Executive Officer, RealMata
Maga Chinauta
Chief Financial Officer, RealMata
Dr. Yair Lotan
Chief of Uro-Oncology, University of Texas Southwestern Medical Center
Matt Barkas
Analyst, Jefferies
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Relmada Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.656 Good afternoon. Welcome to Vermont Therapeutics' first quarter 2025 earnings call. 00:00:05.656 -- 00:00:08.919 At this time, all participants are in a listen-only mode. 00:00:08.919 -- 00:00:12.862 After the prepared remarks, we will conduct a question-and-answer session. 00:00:12.862 -- 00:00:18.327 To ask a question, please press star 1. As a reminder, this conference is being recorded 00:00:18.327 -- 00:00:22.451 and will be available for replay on the location website. 00:00:22.451 -- 00:00:26.394 I would like to turn the call over to Brian Ritchie from Lightside Avire. 00:00:26.394 -- 00:00:29.295 Please go ahead, Mr. Ritchie. 00:00:29.377 -- 00:00:33.320 Good day. And thank you, everyone, for joining us today. 00:00:33.320 -- 00:00:38.587 This afternoon, Ramada issued a press release providing a business update and outlining 00:00:38.587 -- 00:00:44.131 its financial results for the three months ended March 31st, 2025. 00:00:44.494 -- 00:00:49.500 Please note that certain information discussed on the call today is covered under the 00:00:49.500 -- 00:00:54.326 safe harbor provision of the Private Securities Litigation Reform Act. 00:00:54.326 -- 00:00:59.832 We caution listeners that during this call, Ramada's management team will be making forward-looking 00:00:59.832 -- 00:01:04.980 statements. Actual results could differ materially from those stated or 00:01:04.980 -- 00:01:09.987 implied by these forward-looking statements due to risks and uncertainties associated 00:01:09.987 -- 00:01:12.270 with the company's business. 00:01:12.270 -- 00:01:16.917 These forward-looking statements are qualified by the cautionary statements contained 00:01:16.917 -- 00:01:22.225 in Ramada's press release issued today and the company's SE...